Apr 14, 2022
Dave Rosa is the President and CEO of NeuroOne and an entrepreneur with extensive experience in the medical device industry. NeuroOne is developing and commercializing thin-film high-definition electrode technology that can dramatically improve neurosurgery where typically, multiple surgeries are needed for diagnostic and therapeutic procedures. Using a photolithographic process to print out these circuits is a distinct advantage over the outdated approach to manufacturing electrodes by hand.
Dave elaborates, "Another key piece of what we're looking to accomplish is to really reduce the number of surgeries that a patient has to undergo by combining multiple functions using the same device. So, when I refer to electrode functions, what I'm really talking about is the ability to record electrical activity in the brain, or other areas of the body, stimulate the tissue for therapeutic purposes, or perform an ablation, which is basically destroying problematic tissue that patients would have if they had epilepsy."
"All the commercially available electrodes that are cleared by the FDA are fairly thick and not flexible. That becomes really important, the flexibility and thinness when you're trying to insert these through minimally invasive procedures. So, for example, in the spine, the thinness and flexibility of our device allow you to basically roll it up into a tube and push it through a needle, which is commonly used in back surgery procedures. Or you can create smaller holes in the skull to insert these electrodes, as opposed to having to remove the entire part of the skull."
@N1MTC #Electrodes #ThinFilmElectrodes #ParkinsonsDisease #Neurosurgery #BrainSurgery #Epilepsy #Depression #ChronicBackPain #MedicalDevices
